Matthew Schellenberg, Ph.D. (BMB ’19), receives an award, Mayo Clinic Rochester

Matthew Schellenberg, Ph.D. (BMB ’19), Department of Biochemistry and Molecular Biology at Mayo Clinic in Rochester, received a Developmental Research Program award from the Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE) for the project “Defining the Molecular Mechanism of HSD17b4 Targeting by Endoxifen in Breast Cancer Endocrine Therapy Treatment.” The Mayo Clinic Breast Cancer SPORE Developmental Research Program awards are given for innovative laboratory, population and clinical study proposals that include interdisciplinary collaboration and demonstrate the potential to generate new hypotheses that can be tested in larger-scale research projects or clinical trials. Dr. Schellenberg is an assistant professor of biochemistry and molecular biology in the Mayo Clinic College of Medicine and Science.

Recommended reading

Posts about similar topics: